Tinninus Assessment Technology

MENODYS’s Tinnitus Assessment Technology featured in medGadget’s Ear, Nose and Throat Diagnostic and Surgical Devices Pipeline Review, 2015

Longueuil, Quebec, Canada – MENODYS and its Tinnitus Assessment Technology are featured in the Ear, Nose and Throat Diagnostic and Surgical Devices Pipeline Review, 2015 of medGadget, the web-based medical technology news source, dated September 18th 2015. Exclusively licenced to MENODYS and invented by Pr Sylvie Hébert and Philippe Fournier of the School of Speech Pathology and Audiology of the University of Montreal, the Tinnitus Assessment Technology offers audiology specialists around the world a faster and objective approach to assess the frequency spectrum and amplitude of their patient’s tinnitus. This medical technology will thus allow audiology specialists to better design the symptoms attenuation protocol of the patient’s tinnitus.

“Being part of such international market research studies is a confirmation of our business model of bringing innovative medical technology ideas to the market and for international medical device companies to take on their commercialization. We have recently completed the development and validation of the technology and we have initiated discussions with possible commercialization partners with the hope of quickly bringing this innovative approach in audiology to the growing worldwide population suffering from tinnitus”, said Richard Côté, Executive Vice President of MENODYS.

Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians, 30 million Americans and more than 120 million Europeans.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

 

 

Tinninus Assessment Technology

MENODYS launches the clinical validation of its Tinnitus Assessment Technology

Longueuil, Quebec, Canada – MENODYS is proud to announce the launch of the clinical validation phase of its tinnitus assessment technology.

This important milestone is reached following the successful completion of prototypes enabling the assessment of tinnitus based on the developed university bench version. Invented by Pr Sylvie Hébert and Philippe Fournier of the School of Speech Pathology and Audiology at the University of Montreal, the device will offer audiology specialists around the world a rapid and innovative approach to objectively assess the frequency and amplitude of their patient’s tinnitus. This medical technology will thus allow audiology specialists to precisely design the symptom attenuation protocol for the patient’s tinnitus. The clinical validation will involve adults suffering from tinnitus and will be performed at the department of audiology of the University of Montreal, Quebec, Canada.

“We are excited with the rapid development process of this much needed medical device innovation for an important unmet need in audiology. This clinical validation will confirm the published results of this new technological concept and bring us a step closer to offering this innovation worldwide to tinnitus patients and audiology professionals”, said Richard Côté, Executive Vice President of MENODYS.

Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians, 30 million Americans and more than 120 million Europeans.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

LT10 Surgical Magnetic Mat

The LT10G™ Surgical Magnetic Mat to be showcased at the AQLASS 2015 meeting

Longueuil, Quebec, Canada – MENODYS’s LT10G™ Surgical Magnetic Mat will be presented to the 300 participants of the Quebec Association of Logistics and Purchasing of the Healthcare Sector (AQLASS) annual meeting on June 12th in Mont-Tremblant, Quebec. “This is a tremendous opportunity for MENODYS to showcase its first commercialized medical innovation, the LT10G™, to the most important meeting of hospital buyers from the province of Quebec” said Richard Côté, Executive Vice President of MENODYS.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

About AQLASS

Founded in 1967, the AQLASS is the oldest Canadian provincial purchasing association of the healthcare sector. For more information visit: www.aqlass.org

Tinninus Assessment Technology

MENODYS launches the prototyping of its Tinnitus Assessment Technology

Longueuil, Quebec, Canada – MENODYS is proud to announce the launch of the prototyping phase of its tinnitus assessment technology. Invented by Pr Sylvie Hébert and Philippe Fournier of the School of Speech Pathology and Audiology of the University of Montreal, the device will offer audiology specialists around the world an innovative approach to objectively assess the frequency and amplitude of tinnitus.

Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians, 30 million Americans and more than 120 million Europeans.

“ We are excited to launch the development of the Tinnitus Assessment Technology, the third technology in MENODYS’ portfolio, which confirms the acceleration of our business plan of developing and commercializing innovations in the medical device sector” said René Gosselin, President at MENODYS.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

LT10 Surgical Magnetic Mat

An innovation of the Maisonneuve-Rosemont Hospital commercialized in 70 countries

Montreal, Quebec, Canada – Dr Louis-Philippe Fortier, chief of anesthesiology at Maisonneuve-Rosemont Hospital, a University of Montreal affiliated university health centre, with the collaboration of Dr Valérie Zaphiratos, anesthesiologist, have developed a new generation magnetic surgical mat offering more security for patients wearing an electronic implant and going through a surgical procedure. Surgical magnetic mats are used in operating procedures to maintain surgical instruments at the proximity of the operating site and thus minimizing risks of injury caused by transfer of sharp instruments between operating room staff. With the partnership of MENODYS, a Quebec medical device company that develops innovative medical technologies, the LT10G™ Surgical Magnetic Mat will soon be sold in over 70 countries including Canada.

“We observed magnetic inferences between a surgical magnetic mat and a patient’s pacemaker for the first time 4 years ago. To validate if this issue was unique, we put together an experimental protocol to measure the magnetic interferences caused by the surgical magnetic mat we use at the hospital on 50 patients wearing a pacemaker,” explains Dr Fortier.

The results of this study were published in Anesthesia & Analgesia in March 2013: 47 of the 50 pacemakers were affected. The involuntary capture of a patient’s pacemaker with normal vital signs represents a risk for the patient’s safety and security. In fact, the magnetic interference may falsify the reading of the patient’s status. As surgical magnetic mats are commonly used by surgeons to maintain surgical instruments in proximity, the idea of developing a more secure mat came logically to Dr Fortier.

In collaboration with MENODYS, Dr Fortier developed a surgical magnetic mat that offers a unilateral magnetic flux. In comparison with other commercially available magnetic surgical mat, the LT10G™ generates Less Than 10 Gauss at its undersurface, thus no magnetic interference on electronic implants while offering the same functionality to support surgical instruments at its surface.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

About Maisonneuve-Rosemont Hospital

Affiliated to the University of Montreal, the Maisonneuve-Rosemont Hospital (HMR) is a major health institution for healthcare, teaching and medical research since 1954. Its 5500 employees and doctors offers health services to the large eastern Montreal population. HMR host a prominent research center with 4 prominent sectors: hemato-oncology, vision care, nephrology and cellular therapy. for more information please visit: www.maisonneuve-rosemont.org

Tinninus Assessment Technology

MENODYS and Univalor announce the signature of an exclusive agreement to develop and commercialize an innovative technology for the objective assessment of tinnitus

Longueuil, Quebec, Canada – MENODYS and Univalor, the University of Montreal’s office of technology transfer, have agreed to the terms of an exclusive license option to a medical technology developed by Pr Sylvie Hébert, of the School of Speech Pathology and Audiology of the University of Montreal.

This technology offers a new approach for the objective assessment of the frequency and amplitude of tinnitus. Tinnitus is an important health issue in audiology affecting more than 360 000 Canadians and 30 millions Americans.

The agreement is the second to take place between Univalor and MENODYS will accelerate the development and marketing of a technology targeting a specific need. “We look forward to work again with MENODYS who proved to be a worthy partner in the commercialization of innovations in the sector of medical technology,” said Clermont Beaulieu, manager in Life Sciences at Univalor.

“ We are excited about this new agreement with Univalor which confirms our business model of accelerating the transfer and international commercialization of innovations in the medical device sector” said Richard Côté, Executive vice president at MENODYS.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

About Univalor

Univalor is a university technology transfer organization that has been commercializing scientific findings and technological innovations emanating from some 2,600 researchers at the Université de Montréal and its affiliated health centres, Polytechnique Montréal and HEC Montréal, in the areas of pure and applied sciences, engineering, information technology, management sciences, life sciences and human health. By creating links between the university and the business community, Univalor helps make businesses more competitive, generate revenue for research and, most importantly, enrich society. www.univalor.ca/en

LT10 Surgical Magnetic Mat

DeRoyal and MENODYS announce the signature of an exclusive worldwide supply agreement for the LT10G™ Surgical Magnetic Mat

KNOXVILLE, Tennessee, USA – DeRoyal announces the signature of an exclusive worldwide supply agreement with MENODYS of Longueuil, Quebec, Canada for the international commercialization of MENODYS’s LT10G™ reusable Magnetic Surgical Mat in over 70 countries. The LT10G™, MENODYS’s first developed medical technology, is a patent pending magnetic surgical mat offering added protection for patients wearing an electronic implant and having a surgical procedure.  The LT10G™ Surgical Magnetic Mat is shielded such that it produces no magnetic interference at its undersurface. The name “LT10G” stands for “Less Than 10 Gauss”. Surgical magnetic mats are commonly used in operating rooms to minimize hand transfer of surgical instruments to help reduce the risks of sharps-related injuries.

David Watermeier, Director of International Marketing for DeRoyal stated, “DeRoyal has marketed and sold disposable magnetic instrument pads for over25 years.  In light of the publication of several studies and the US FDA reporting of adverse events related to electromagnetic interference this provides the market with a product that is safer to use on patient populations with pacemakers and other electronic implants. Furthermore, a reusable mat will prove to be more economical in many markets outside the US where disposable products are not customary.”

About DeRoyal

Founded in 1973, medical device manufacturer DeRoyal is committed to improving both the clinical quality and economic health of its customers. With 2,000 employees, 2.5 million square feet (~232,000 square meters) under roof, operations in six countries and five U.S. states, and manufacturing assets on three continents, DeRoyal brings value to its customers in several distinct markets; these include surgical devices, unitized delivery systems, orthopedic supports & bracing, wound care dressings as well as orthopedic implants. Key core competencies include injection molding, device assembly, metal fabrication, converting, electronics assembly, and sterilization services. DeRoyal combines these fundamental manufacturing capabilities with its own unique services and information technology tools to deliver unparalleled value to its customers with a particular expertise in disrupting dysfunctional markets.

For additional DeRoyal product information, please call 1-888-938-7828 within the USA; or +1-865-938-7828 from outside the USA. Visit the DeRoyal website at www.deroyal.com.

About MENODYS

MENODYS Inc. is a Canadian company specialized in the development and commercialization of medical technologies. For additional information on MENODYS please visit www.menodys.com or call Richard Côté, EVP at +1-514-667-0108.

LT10 Surgical Magnetic Mat

A new study shows that surgical magnetic drapes cause magnetic interference on cardiac pacemakers

Longueuil, Quebec, Canada – MENODYS announces that the March 2013 edition of Anesthesia & Analgesia (2013, 116:555-9) presents the results of a recent study showing the magnetic interferences caused by magnetic surgical drapes on patients wearing pacemakers during surgical procedures. The study, headed by Dr. Louis-Philippe Fortier, chief of anesthesiology at Maisonneuve-Rosemont Hospital, a University of Montreal affiliated center, measured magnetic interferences of commercially available magnetic surgical drapes on the pacemaker of 47 of the 50 patients included in the study. MENODYS has developed and commercializes the LT10G MagMat, a new patent pending surgical magnetic drape specifically designed for not interfering with electronic implants worn by patients. Magnetic drapes are used by surgeons to keep surgical instruments close to the operating site.

About MENODYS

MENODYS is a Canadian company specialized in the development and commercialization of medical technologies. www.menodys.com

LT10 Surgical Magnetic Mat

The July 2013 issue of Anesthesiology News features an article on the LT10G™ Surgical Magnetic Mat of MENODYS

Longueuil, Quebec, Canada – The July 2013 issue of Anesthesiology News (volume 38:7) presents an article entitled: Prototype Shields Pacemakers From Magnetic Drapes. This article details the properties of MENODYS’s LT10G™ Mag Mat, a new, patent pending, Magnetic Surgical Drape that has been developed and proven effective in 2 clinical trials to protect patients wearing electronic implants from magnetic interferences caused by magnetic surgical drapes used in surgical procedures. The paper can be found at:

http://m.anesthesiologynews.com/Article.aspx?d=PRN&d_id=21&i=July+2013&i_id=978&a_id=23529

About MENODYS

MENODYS Inc. is a Canadian company specialized in the development, commercialization and distribution of medical technologies. For more information on MENODYS, please visit www.menodys.com